2026 NPPES data Dermatology Physician NPI 1033105457 M.D.
Verify on CMS →

DAVID SPOTT, M.D.

Dermatology Physician in CLINTON, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
955
Medicare Part D claims · 345 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]

What the federal data shows

DAVID SPOTT, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 955 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
955
Part D claims, 2023
94%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DAVID SPOTT, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DAVID SPOTT, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DAVID SPOTT, M.D.?

Below national average

NPI registry status

Active

Issued 09/21/2005

NPI 1033105457

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

955 31% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Maryland

How Dermatology Physician compares to other specialties among Maryland providers

Maryland providers

Dermatology Physician share within Maryland

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Maryland

Medicare quality performance — MIPS

DAVID SPOTT, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID SPOTT, M.D. is a Dermatology Physician provider practicing in CLINTON, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1033105457. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID SPOTT, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 9131 PISCATAWAY RD, CLINTON, MD, 20735, with a listed phone of (301) 868-7077. NPI 1033105457 was issued on 09/21/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SPOTT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 955 prescription claims written by this provider, covering 345 Medicare beneficiaries and totaling roughly $108K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9131 PISCATAWAY RD
CLINTON, MD 20735

Provider Details

NPI 1033105457
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 09/21/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Brand vs generic prescribing mix · Generic-heavy

DAVID SPOTT, M.D. — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 955 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

955
Total Claims
$108K
Total Drug Cost
345
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,008
Total Day Supply
25,287
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$71K
Generic Drug Cost
$37K
Antibiotic Claims
67

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.31
Gender Split
58% female / 42% male
Age Distribution
<65: 40, 65-74: 149, 75-84: 126, 85+: 30

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
222
Mometasone Furoate
141
Clobetasol Propionate
77
Halobetasol Propionate
47
Triamcinolone Acetonide
44
Fluticasone Propionate
37
Betamethasone Dipropionate
33
Cephalexin
28
Doxycycline Hyclate
27
Hydroxyzine Hcl
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How DAVID SPOTT, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

DAVID SPOTT, M.D.'s 955 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as SPOTT.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID SPOTT, M.D.'s specialty?
DAVID SPOTT, M.D. specializes in Dermatology Physician and practices in CLINTON, Maryland. Credentials: M.D..
How much does DAVID SPOTT, M.D. prescribe under Medicare Part D?
In 2023, DAVID SPOTT, M.D. wrote 955 Medicare Part D claims totaling $108K in drug costs for 345 beneficiaries.
What is DAVID SPOTT, M.D.'s Medicare quality score?
DAVID SPOTT, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DAVID SPOTT, M.D. located?
DAVID SPOTT, M.D. is located at 9131 PISCATAWAY RD, CLINTON, MD, 20735. Phone: (301) 868-7077.
What is DAVID SPOTT, M.D.'s NPI number?
DAVID SPOTT, M.D.'s National Provider Identifier (NPI) is 1033105457, issued on 09/21/2005.
Does DAVID SPOTT, M.D. prescribe more brand-name or generic drugs?
DAVID SPOTT, M.D.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $71K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does DAVID SPOTT, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DAVID SPOTT, M.D.'s most frequently prescribed drugs include Betamethasone Diprop Augmented, Mometasone Furoate, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID SPOTT, M.D. accept Medicare?
DAVID SPOTT, M.D. appears in CMS Medicare data with 955 Part D claims and 345 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID SPOTT, M.D.'s credentials?
DAVID SPOTT, M.D.'s NPI is 1033105457 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology